4.3 Article

LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India

期刊

NEUROLOGY INDIA
卷 59, 期 2, 页码 157-160

出版社

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/0028-3886.79125

关键词

G2019S mutation; India; LRRK2; Parkinson's disease

资金

  1. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Kerala, India [5040]

向作者/读者索取更多资源

Background: The frequency of leucine-rich repeat kinase 2 (LRRK2) G2019S mutation, the most common genetic cause of Parkinson's disease (PD), shows significant variation based on ethnicity. Earlier reports suggest a very low frequency or absence of this mutation in Asians. Objective: To analyze the frequency of LRRK2 G2019S mutation in sporadic and familial cases of PD and normal controls of common ethnicity from South India. Patients and Methods: We used direct sequencing technique of all DNA samples in a clinic-based study of sporadic (n = 100) and familial PD patients (n = 86 index cases) and normal controls (n = 100) of common ethnicity from South India. Results: None among the patients or controls had the G2019S mutation. Conclusion: The founding events that influenced a number of other populations/ethnicities had no impact on the genetic makeup of PD patients from South India. Our findings support the current view that G2019S-associated PD may be population-specific. This has implications in genetic testing for PD and selection of subjects for potential future gene-based therapeutic trials for G2019S carriers in such populations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据